A 75-year-old man was referred to our institution for lateral ST-elevation myocardial infarction. He previously underwent a 2.5 × 18 mm sirolimus-eluting stent implantation on the first diagonal branch 9 years earlier for symptomatic stable coronary artery disease. He has been under aspirin for the past 8 years with an uneventful evolution.
Thrombolysis, clopidogrel-loading dose, and enoxaparin were given 2 h after symptom onset, leading to prompt reperfusion (cessation of chest pain and ST-segment elevation normalization). Control coronary angiography revealed an intermediate stenosis on the proximal left anterior descending artery and no visible lesion within the stent (Panel A, arrows; Supplementary material online, Video S1). Optical coherence tomography analysis of this stent was then performed (Supplementary material online, Video S2). It showed correct neointimal coverage of the distal part of the stent (Panel B), but residual thrombus (Panel C, arrows), as well as uncovered struts (Panels C and D, arrowheads) and stent malapposition (Panel D, arrows) were observed on the proximal part of the stent. The final diagnosis was STEMI related to very late sirolimus-stent thrombosis consecutive to incomplete neointimal struts coverage. The troponin Ic peak was 64.8 mg/L. Echocardiography revealed lateral wall hypokinesia and left ventricle ejection fraction was measured to 50%. The patient was discharged under long-term double antiplatelet therapy (ticagrelor+aspirin).
This case illustrates that extremely delayed re-endothelialization process within the first generation drug-eluting stents exists and could eventually cause thrombotic complications many years after initial deployment. Optical coherence tomography imaging appears a valuable tool for culprit lesion identification and pathophysiology characterization in this situation.
Supplementary material is available at European Heart Journal online. 
